European Commission Question & Answer Document for Patients Builds Trust and Understanding on Biosimilar Medicines across Europe

25 October 2016

Today, the European Commission published a Q&A for patients on […]

EU countries urged to promote generics, biosimilars to meet rising costs of long-term care – report

18 October 2016

LONDON, Oct 18 (APM) – European countries should promote greater […]

NOR-SWITCH Study: Another Significant Example of Positive Real World Evidence on Physician-led Switching to Biosimilar Medicines

18 October 2016

Today at the United Gastro-Enterology (UEG) week in Vienna, the NOR-SWITCH […]

European Commission Strongly Recommends the Use of Generic and Biosimilar Medicines to Ensure the Sustainability of Healthcare Systems

14 October 2016

Medicines for Europe welcomes the publication of the ‘Joint Report […]

Generic medicines have enabled twice as many patients to get treatment for the same budget

12 October 2016

Presentation of the report “The Value of Generic Medicines” GENERIC […]

The Value Added Medicines Group Highlights the Importance of Access to Health during the CPhI Conference

3 October 2016

The Value Added Medicines Group a sector group of Medicines […]

Generic Medicines at the Heart of the French Public Health System

30 September 2016

Medicines for Europe strongly supports the French government campaign to […]

The global scourge of counterfeit medicines

29 September 2016

Generic Medicines save European Countries 100 Billion Euro per Year

28 September 2016

Lisbon, September 28, 2016 – Without the use of generic […]

Generic Medicines Increase Access to Treatments

27 September 2016